Insights from 2023 ASCO® Annual Meeting
Playback speed
10 seconds
ASCO® 2023 Insights: "Phase III FIRE-4 Study - Influence of Baseline Liquid Biopsy Results in 1L Treatment Efficacy of FOLFIRI/Cetuximab in Pts With Tissue RAS-WT mCRC"
876 views
June 15, 2023
Comments 0
Login to view comments.
Click here to Login
GI